Lars Ege Rasmussen

Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation

Lars Ege Rasmussen, Arnljot Tveit, Eva C. Jensen et al. · Thrombosis and Haemostasis · 2010 · 52 citations

Three‐dimensional multidetector computed tomography versus conventional 2‐dimensional transesophageal echocardiography for annular sizing in transcatheter aortic valve replacement: Influence on postprocedural paravalvular aortic regurgitation

Nicolaj C. Hansson, Leif Thuesen, Vibeke E. Hjortdal et al. · Catheterization and Cardiovascular Interventions · 2013 · 43 citations

Amino acid transamination is crucial for ischaemic cardioprotection in normal and preconditioned isolated rat hearts – focus on <scp>l</scp>‐glutamate

Bo Løfgren, Jonas Agerlund Povlsen, Lars Ege Rasmussen et al. · Experimental Physiology · 2009 · 37 citations · Full text

Cardiac Muscle, Heart Failure, Ischaemic Cardioprotection +19

The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease

Lars Ege Rasmussen, My Svensson, Kaj Anker Jørgensen et al. · Nutrition Research · 2010 · 25 citations

Docosahexaenoic Acid, Metabolic Syndrome, Urology +13